Lester C. Barnsley

Lester C. Barnsley

Auto-generated profile, based on publicly available information

Lester C. Barnsley

Australian Synchrotron, 800 Blackburn Road, Clayton, Victoria 3168, Australia

Research Focus & Metrics

Academic Career Length

17Years (2010-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
14 August 2020 in Macromolecules
Verified
Journal Article
Closed access
CKChia-Hsin Ko
Chia-Hsin Ko
KCKora-Lee Claude
Kora-Lee Claude
BNBart-Jan Niebuur
Bart-Jan Niebuur
FJFlorian A. Jung
Florian A. Jung
JKJia-Jhen Kang
Jia-Jhen Kang
CPChristine M. Papadakis
Christine M. Papadakis

12 October 2015 in Physics in Medicine & Biology
Verified
Journal Article
Closed access
PDF file
LBLester C Barnsley
Lester C Barnsley
Dario CarugoDario Carugo
Dario Carugo
JOJoshua Owen
Joshua Owen
ESEleanor Stride
Eleanor Stride
A key challenge in the development of magnetic drug targeting (MDT) as a clinically relevant technique is designing systems that can apply sufficient magnetic force to actuate magnetic drug carriers at useful tissue depths. In this study an optimisation routine was developed to generate designs of Halbach arrays consisting of multiple layers of high grade, cubic, permanent magnet elements, configured to deliver the maximum pull or push force at a position of interest between 5 and 50 mm from the array, resulting in arrays capable of delivering useful magnetic forces to depths past 20 mm. The optimisation routine utilises a numerical model of the magnetic field and force generated by an arbitrary configuration of magnetic elements. Simulated field and force profiles of optimised arrays were evaluated, also taking into account the forces required for assembling the array in practice. The resultant selection for the array, consisting of two layers, was then constructed and characterised to verify the simulations. Finally the array was utilised in a set of in vitro experiments to demonstrate its capacity to separate and retain microbubbles loaded with magnetic nanoparticles against a constant flow. The optimised designs are presented as light-weight, inexpensive options for applying high-gradient, external magnetic fields in MDT applications.

1 September 2017 in Journal of Controlled Release
Verified
Journal Article
Open access
YSYingjie Sheng
Yingjie Sheng
EBEstelle Beguin
Estelle Beguin
HNHeather Nesbitt
Heather Nesbitt
SKSukanta Kamila
Sukanta Kamila
JOJoshua Owen
Joshua Owen
JCJohn F Callan
John F Callan
Magnetically responsive microbubbles (MagMBs), consisting of an oxygen gas core and a phospholipid coating functionalised with Rose Bengal (RB) and/or 5-fluorouracil (5-FU), were assessed as a delivery vehicle for the targeted treatment of pancreatic cancer using combined antimetabolite and sonodynamic therapy (SDT). MagMBs delivering the combined 5-FU/SDT treatment produced a reduction in cell viability of over 50% when tested against a panel of four pancreatic cancer cell lines in vitro. Intravenous administration of the MagMBs to mice bearing orthotopic human xenograft BxPC-3 tumours yielded a 48.3% reduction in tumour volume relative to an untreated control group (p<0.05) when the tumour was exposed to both external magnetic and ultrasound fields during administration of the MagMBs. In contrast, application of an external ultrasound field alone resulted in a 27% reduction in tumour volume. In addition, activated caspase and BAX protein levels were both observed to be significantly elevated in tumours harvested from animals treated with the MagMBs in the presence of magnetic and ultrasonic fields when compared to expression of those proteins in tumours from either the control or ultrasound field only groups (p<0.05). These results suggest MagMBs have considerable potential as a platform to enable the targeted delivery of combined sonodynamic/antimetabolite therapy in pancreatic cancer.

1 January 2020 in Journal of Controlled Release
Verified
Journal Article
Open access
EBEstelle Beguin
Estelle Beguin
MGMichael D. Gray
Michael D. Gray
KLKeiran A. Logan
Keiran A. Logan
HNHeather Nesbitt
Heather Nesbitt
YSYingjie Sheng
Yingjie Sheng
ESEleanor Stride
Eleanor Stride
Recent pre-clinical studies have demonstrated the potential of combining chemotherapy and sonodynamic therapy for the treatment of pancreatic cancer. Oxygen-loaded magnetic microbubbles have been explored as a targeted delivery vehicle for this application. Despite preliminary positive results, a previous study identified a significant practical challenge regarding the co-alignment of the magnetic and ultrasound fields. The aim of this study was to determine whether this challenge could be addressed through the use of a magnetic-acoustic device (MAD) combining a magnetic array and ultrasound transducer in a single unit, to simultaneously concentrate and activate the microbubbles at the target site. in vitro experiments were performed in tissue phantoms and followed by in vivo treatment of xenograft pancreatic cancer (BxPC-3) tumours in a murine model. In vitro, a 1.4-fold (p < .01) increase in the deposition of a model therapeutic payload within the phantom was achieved using the MAD compared to separate magnetic and ultrasound devices. In vivo, tumours treated with the MAD had a 9% smaller mean volume 8 days after treatment, while tumours treated with separate devices or microbubbles alone were respectively 45% and 112% larger. This substantial and sustained decrease in tumour volume suggests that the proposed drug delivery approach has the potential to be an effective neoadjuvant therapy for pancreatic cancer patients.

24 July 2020 in Physical Review X
Verified
Journal Article
Open access
PDF file
Dominika ZákutnáDominika Zákutná
Dominika Zákutná
DNDaniel Nižňanský
Daniel Nižňanský
LBLester C. Barnsley
Lester C. Barnsley
EBEarl Babcock
Earl Babcock
ZSZahir Salhi
Zahir Salhi
SDSabrina Disch
Sabrina Disch
The performance characteristics of magnetic nanoparticles toward application, e.g., in medicine and imaging or as sensors, are directly determined by their magnetization relaxation and total magnetic moment. In the commonly assumed picture, nanoparticles have a constant overall magnetic moment originating from the magnetization of the single-domain particle core surrounded by a surface region hosting spin disorder. In contrast, this work demonstrates the significant increase of the magnetic moment of ferrite nanoparticles with an applied magnetic field. At low magnetic field, the homogeneously magnetized particle core initially coincides in size with the structurally coherent grain of 12.8(2) nm diameter, indicating a strong coupling between magnetic and structural disorder. Applied magnetic fields gradually polarize the uncorrelated, disordered surface spins, resulting in a magnetic volume more than 20% larger than the structurally coherent core. The intraparticle magnetic disorder energy increases sharply toward the defect-rich surface as established by the field dependence of the magnetization distribution. In consequence, these findings illustrate how the nanoparticle magnetization overcomes structural surface disorder. This new concept of intraparticle magnetization is deployable to other magnetic nanoparticle systems, where the in-depth knowledge of spin disorder and associated magnetic anisotropies are decisive for a rational nanomaterials design.

1 May 2019 in Ultrasound in Medicine & Biology
Verified
Journal Article
Open access
MVMarie de Saint Victor
Marie de Saint Victor
LBLester C. Barnsley
Lester C. Barnsley
Dario CarugoDario Carugo
Dario Carugo
JOJoshua Owen
Joshua Owen
CCConstantin C. Coussios
Constantin C. Coussios
ESEleanor Stride
Eleanor Stride
Microbubble-enhanced sonothrombolysis is a promising approach to increasing the tolerability and efficacy of current pharmacological treatments for ischemic stroke. Maintaining therapeutic concentrations of microbubbles and drugs at the clot site, however, poses a challenge. The objective of this study was to investigate the effect of magnetic microbubble targeting upon clot lysis rates in vitro. Retracted whole porcine blood clots were placed in a flow phantom of a partially occluded middle cerebral artery. The clots were treated with a combination of tissue plasminogen activator (0.75 µg/mL), magnetic microbubbles (∼107 microbubbles/mL) and ultrasound (0.5 MHz, 630-kPa peak rarefactional pressure, 0.2-Hz pulse repetition frequency, 2% duty cycle). Magnetic targeting was achieved using a single permanent magnet (0.08-0.38 T and 12-140 T/m in the region of the clot). The change in clot diameter was measured optically over the course of the experiment. Magnetic targeting produced a threefold average increase in lysis rates, and linear correlation was observed between lysis rate and total energy of acoustic emissions.